2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Xiaodong Sun: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy OCTA plus OCT guided 3+PRN regimen, OCT guided 3+PRN regimen, Anti-VEGF drug - Polypoidal Choroidal Vasculopathy | Phase 4 | Unknown | Xiaodong Sun | 102 | 2020-06-01 | 2020-05-08 |
| Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration Treat-and-Extend regimen, Pro Re Nata, Conbercept - Age-related Macular Degeneration | Phase 4 | Unknown | Xiaodong Sun | 141 | 2016-09-01 | 2020-05-19 |
Macular Degeneration (1) · Polypoidal Choroidal Vasculopathy (1)
China (2)